Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 4,000 shares at $39.37 ($154K) on 2015-01-02, disclosed to the SEC on 2015-01-05.
Scheduled sale ($154k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.36 | 3,600 | $138K | 89.8% |
| 2 | $39.37 | 400 | $16K | 10.2% |
| Total | $38.46 avg | 4,000 | $154K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |